Translational Development Acquisition Corp. (TDAC) stock
TDACNasdaqBlank ChecksFiscal year ends December 31Also trades as TDACU, TDACW
$10.87+0.01 (+0.09%)
Close on Nov 17, 2026Market cap $209.89MP/E –Yield –
Translational Development Acquisition operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Translational Development Acquisition's operating cash flow for the twelve months ending Jun 30, 2026 was -$849.38K. For fiscal 2025 it was -$608.39K.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$608.39K | – |
| FY2024 | Dec 31, 2024 | -$851.45K | – |
| FY2023 | Dec 31, 2023 | -$204 | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$338.75K | – |
| Q1 FY2026 | Mar 31, 2026 | -$305.16K | – |
| Q4 FY2025 | Dec 31, 2025 | -$117.36K | – |
| Q3 FY2025 | Sep 30, 2025 | -$88.11K | – |
| Q2 FY2025 | Jun 30, 2025 | -$171.35K | – |
| Q1 FY2025 | Mar 31, 2025 | -$231.57K | – |
| Q4 FY2024 | Dec 31, 2024 | -$810.96K | – |
See a number that looks wrong?